DEFINING A SIZE THRESHOLD FOR PERCUTANEOUS MICROWAVE ABLATION FOR CLINICAL T1 RENAL CELL CARCINOMA BY COMPARING ONCOLOGIC OUTCOMES WITH SURGICALLY TREATED PATIENTS

被引：0
|
作者：
Arighno, Das
Daniel, Shapiro
Louis, Hinshaw J.
Timothy, Ziemlewicz
Paul, Laeseke
Fred, Lee
Jason, Abel E.
Shane, Wells
Tudor, Borza
机构：
[1] Univ Wisconsin, Madison, WI 53706 USA
[2] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷
关键词：
D O I：
10.1016/j.urolonc.2024.01.203
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
166
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [1] Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery
    Shapiro, Daniel D.
    Wells, Shane A.
    Best, Sara L.
    Hedican, Sean P.
    Ziemlewicz, Timothy J.
    Lubner, Meghan G.
    Hinshaw, James Louis
    Lee, Fred T., Jr.
    Jarrard, David F.
    Richards, Kyle A.
    Downs, Tracy M.
    Allen, Glenn O.
    Nakada, Stephen Y.
    Abel, Edwin Jason
    UROLOGY, 2020, 135 : 88 - 94
  • [2] Re: Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated with either Percutaneous Microwave Ablation or Surgery
    Laguna, M. Pilar
    JOURNAL OF UROLOGY, 2020, 203 (06): : 1058 - 1059
  • [3] Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma
    Maciolek, Kim A.
    Abel, E. Jason
    Posielski, Natasza M.
    Hinshaw, J. Louis
    Lubner, Meghan G.
    Lee, Fred T., Jr.
    Ziemlewicz, Timothy J.
    Wells, Shane A.
    EUROPEAN RADIOLOGY, 2019, 29 (11) : 6319 - 6329
  • [4] Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma
    Kim A. Maciolek
    E. Jason Abel
    Natasza M. Posielski
    J. Louis Hinshaw
    Meghan G. Lubner
    Fred T. Lee
    Timothy J. Ziemlewicz
    Shane A. Wells
    European Radiology, 2019, 29 : 6319 - 6329
  • [5] Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma
    B. M. Aarts
    W. Prevoo
    M. A. J. Meier
    A. Bex
    R. G. H. Beets-Tan
    E. G. Klompenhouwer
    F. M. Gómez
    CardioVascular and Interventional Radiology, 2020, 43 : 1025 - 1033
  • [6] Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma
    Aarts, B. M.
    Prevoo, W.
    Meier, M. A. J.
    Bex, A.
    Beets-Tan, R. G. H.
    Klompenhouwer, E. G.
    Gomez, F. M.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 43 (07) : 1025 - 1033
  • [7] Long-Term Oncologic Outcomes After Radiofrequency Ablation for T1 Renal Cell Carcinoma
    Psutka, Sarah P.
    Feldman, Adam S.
    McDougal, W. Scott
    McGovern, Francis J.
    Mueller, Peter
    Gervais, Debra A.
    EUROPEAN UROLOGY, 2013, 63 (03) : 486 - 492
  • [8] A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
    Jie Yu
    Hui Wang
    Zhi-Gang Cheng
    Fang-Yi Liu
    Qin-ying Li
    Guang-zhi He
    Yan-chun Luo
    Xiao-Ling Yu
    Zhi-Yu Han
    Ping Liang
    European Radiology, 2022, 32 : 89 - 100
  • [9] A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
    Yu, Jie
    Wang, Hui
    Cheng, Zhi-Gang
    Liu, Fang-Yi
    Li, Qin-ying
    He, Guang-zhi
    Luo, Yan-chun
    Yu, Xiao-Ling
    Han, Zhi-Yu
    Liang, Ping
    EUROPEAN RADIOLOGY, 2022, 32 (01) : 89 - 100
  • [10] Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma
    Li, G.
    Zhu, D.
    Gao, H.
    Chen, H.
    Li, Y.
    Niu, Y.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (06): : 760 - 765
12345